Chemotherapy induced fatigue - risks and prevalence

Publikation: Bidrag til tidsskriftTidsskriftartikelfagfællebedømt

Standard

Chemotherapy induced fatigue - risks and prevalence. / Adnan, Ala; Brix Tange, Ulla; Honoré, Per Gustaf Hartvig.

I: Farmacja Onkologiczna, Bind 3, Nr. 16, 2010, s. 23-30.

Publikation: Bidrag til tidsskriftTidsskriftartikelfagfællebedømt

Harvard

Adnan, A, Brix Tange, U & Honoré, PGH 2010, 'Chemotherapy induced fatigue - risks and prevalence', Farmacja Onkologiczna, bind 3, nr. 16, s. 23-30.

APA

Adnan, A., Brix Tange, U., & Honoré, P. G. H. (2010). Chemotherapy induced fatigue - risks and prevalence. Farmacja Onkologiczna, 3(16), 23-30.

Vancouver

Adnan A, Brix Tange U, Honoré PGH. Chemotherapy induced fatigue - risks and prevalence. Farmacja Onkologiczna. 2010;3(16):23-30.

Author

Adnan, Ala ; Brix Tange, Ulla ; Honoré, Per Gustaf Hartvig. / Chemotherapy induced fatigue - risks and prevalence. I: Farmacja Onkologiczna. 2010 ; Bind 3, Nr. 16. s. 23-30.

Bibtex

@article{0b261345d8ff4ec3a89ec05d1b990619,
title = "Chemotherapy induced fatigue - risks and prevalence",
keywords = "Det tidligere Farmaceutiske Fakultet",
author = "Ala Adnan and {Brix Tange}, Ulla and Honor{\'e}, {Per Gustaf Hartvig}",
year = "2010",
language = "Dansk",
volume = "3",
pages = "23--30",
journal = "Farmacja Onkologiczna",
issn = "1897-4163",
number = "16",

}

RIS

TY - JOUR

T1 - Chemotherapy induced fatigue - risks and prevalence

AU - Adnan, Ala

AU - Brix Tange, Ulla

AU - Honoré, Per Gustaf Hartvig

PY - 2010

Y1 - 2010

KW - Det tidligere Farmaceutiske Fakultet

M3 - Tidsskriftartikel

VL - 3

SP - 23

EP - 30

JO - Farmacja Onkologiczna

JF - Farmacja Onkologiczna

SN - 1897-4163

IS - 16

ER -

ID: 34058552